ストックスクリーナーアプリを入手
144.85
0.64%
0.92
アフターアワーズ：
144.85
前日終値:
$143.93
開ける：
$146.42
24時間の取引高:
7.37M
Relative Volume:
0.73
時価総額：
$357.37B
収益：
$65.51B
当期純損益:
$8.93B
株価収益率:
40.77
EPS:
3.5532
ネットキャッシュフロー:
$14.12B
1週間 パフォーマンス:
-3.65%
1か月 パフォーマンス:
+6.63%
6か月 パフォーマンス:
+25.29%
1年 パフォーマンス:
+74.92%
1日の値動き範囲:
$144.10
$147.09
1週間の範囲:
$143.68
$149.60
52週間の値動き範囲:
$77.58
$156.92
Merck Co Inc Stock (MRK) Company Profile
Compare MRK vs LLY, JNJ, ABBV, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
144.85 | 355.10B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,138.28 | 994.49B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
266.32 | 640.02B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
261.77 | 454.36B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
138.99 | 260.70B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-02-20 | 開始されました | Barclays | Overweight |
| 2026-02-13 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-10-13 | 再開されました | Citigroup | Neutral |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Neutral |
| 2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-08 | ダウングレード | Truist | Buy → Hold |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
| 2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | アップグレード | UBS | Neutral → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Hold |
| 2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
| 2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 開始されました | Jefferies | Buy |
| 2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-14 | アップグレード | Berenberg | Hold → Buy |
| 2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | Goldman | Buy |
| 2021-12-16 | 開始されました | Daiwa Securities | Neutral |
| 2021-12-13 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-01 | アップグレード | Argus | Hold → Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-05-20 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-08-03 | アップグレード | Goldman | Neutral → Buy |
| 2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-16 | 開始されました | SVB Leerink | Outperform |
| 2019-07-03 | 開始されました | Mizuho | Buy |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 繰り返されました | Citigroup | Buy |
| 2018-10-09 | 再開されました | Guggenheim | Buy |
| 2018-04-23 | アップグレード | Goldman | Neutral → Buy |
| 2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
Merck & Co. stock gains as DBS lifts price target and Q2 2026 revenue grows - ad-hoc-news.de
Merck & Co. stock holds after Wall Street Zen cuts rating - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen - MarketBeat
7,741 Shares in Merck & Co., Inc. $MRK Bought by Talon Private Wealth LLC - MarketBeat
Merck & Co. stock gains as analysts lift price targets on cancer drug progress - ad-hoc-news.de
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP - MarketBeat
Rep. Maria Elvira Salazar Buys Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co. stock heads into the open after a 1.9% drop - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9%Should You Sell? - MarketBeat
Merck (MRK) Dips More Than Broader Market: What You Should Know - Yahoo Finance
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research
Recent Filing Shows That Rep. Maria Elvira Salazar Bought Over $34K Worth of Merck & Co Stock - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $172.00 - MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Here's Why We're Wary Of Buying Merck's (NYSE:MRK) For Its Upcoming Dividend - simplywall.st
National Pension Service Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Integrated Wealth Concepts LLC Acquires 13,850 Shares of Merck & Co., Inc. $MRK - MarketBeat
11,499 Shares in Merck & Co., Inc. $MRK Bought by Blue Edge Capital LLC - MarketBeat
Archford Capital Strategies LLC Has $3.52 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. stock heads into the open after a flat Nasdaq close - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Given New $161.00 Price Target at Leerink Partners - MarketBeat
Merck & Co. stock gains as Guggenheim raises price target on oncology optimism - ad-hoc-news.de
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
Merck & Co. stock heads into the open after a 1.0 percent drop - AD HOC NEWS
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - TradingView
Merck Animal Health Supports Next Generation of Bovine Veterinarians with $90,000 in Scholarships - American Ag Network
Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating - Moomoo
Merck's CEO and research chief will speak online Sept. 14 - Stock Titan
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
The Hashgraph Group, Merck, and PwC Germany Develop Solution for Cocoa Traceability and Digital Product Passports - marketscreener.com
Merck & Co. stock gains on Wells Fargo price target hike and cancer vaccine momentum - AD HOC NEWS
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - tradingview.com
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap - DirectorsTalk Interviews
California State Teachers Retirement System Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Amundi Has $1.59 Billion Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Saudi Central Bank - MarketBeat
NBH Bank Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Old Mission Investment Co LLC Makes New $1.34 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Oakmont Investment Advisors Inc. Invests $3.10 Million in Merck & Co., Inc. $MRK - MarketBeat
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Maloon Powers Pitre Higgins & Dennehy LLC Invests $882,000 in Merck & Co., Inc. $MRK - marketbeat.com
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
1.33%
大文字化:
|
ボリューム (24 時間):